Thus, hsa-miR-127-3p, as an alternative JAK1 inhibitor, may be used to treat autoimmune diseases or their associated organ damages that have abnormal upregulation of JAK1, as seen in the kidney of LN. The gene discussed is JAK1; the disease is lobular neoplasia.